GLYAT and Familial prostate cancer: In our study of prostate cancer cells, Gβγ signaling was manipulated by expressing recombinant Gαt, a specific inhibitor of Gβγ that binds free Gβγ and selectively prevents the activation of Gβγ effectors without interfering with Gα signaling [37, 39].